 | • レポートコード：20QY06-05504 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、抗CD20モノクローナル抗体のグローバル市場について種類別（第一世代抗CD20モノクローナル抗体、第二世代抗CD20モノクローナル抗体、第三世代抗CD20モノクローナル抗体）、用途別（腫瘍、神経、免疫）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・抗CD20モノクローナル抗体市場の概要 ・世界の主要地域別抗CD20モノクローナル抗体市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の抗CD20モノクローナル抗体市場規模2015-2026：種類別（第一世代抗CD20モノクローナル抗体、第二世代抗CD20モノクローナル抗体、第三世代抗CD20モノクローナル抗体） ・世界の抗CD20モノクローナル抗体市場規模2015-2026：用途別（腫瘍、神経、免疫） ・抗CD20モノクローナル抗体の北米市場規模2015-2020 ・抗CD20モノクローナル抗体のヨーロッパ市場規模2015-2020 ・抗CD20モノクローナル抗体の中国市場規模2015-2020 ・抗CD20モノクローナル抗体の日本市場規模2015-2020 ・抗CD20モノクローナル抗体の東南アジア市場規模2015-2020 ・抗CD20モノクローナル抗体のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Genmab、Amgen、Celltrion、Roche、Novartis AG、Pfizer、Biogen、Genentech、Immunomedics、Spectrum Pharmaceuticals、Bio-Rad Laboratories、LFB Biotechnologie） ・抗CD20モノクローナル抗体の製造コスト分析 ・販売チャネル、流通業者、顧客 ・抗CD20モノクローナル抗体の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Anti-CD20 Monoclonal Antibodies Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Anti-CD20 Monoclonal Antibodies market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Anti-CD20 monoclonal antibody is an anti-tumor agent for the treatment of non-hodge B cell malignancy.Unlike conventional treatments, these antibodies attack the CD20 antigen on cancer cells.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Anti-CD20 Monoclonal Antibodies market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Anti-CD20 Monoclonal Antibodies industry.
Based on our recent survey, we have several different scenarios about the Anti-CD20 Monoclonal Antibodies YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Anti-CD20 Monoclonal Antibodies will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Anti-CD20 Monoclonal Antibodies market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Anti-CD20 Monoclonal Antibodies market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Anti-CD20 Monoclonal Antibodies market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Anti-CD20 Monoclonal Antibodies market. The report also includes nautical information, where it shows Anti-CD20 Monoclonal Antibodies market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Anti-CD20 Monoclonal Antibodies market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Anti-CD20 Monoclonal Antibodies market.
Geographical Analysis:
Based on region, the global Anti-CD20 Monoclonal Antibodies market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Anti-CD20 Monoclonal Antibodies market are
Genmab
Amgen
Celltrion
Roche
Novartis AG
Pfizer
Biogen
Genentech
Immunomedics
Spectrum Pharmaceuticals
Bio-Rad Laboratories
LFB Biotechnologie
Segment by Type
First Generation Anti-CD20 Monoclonal Antibody
Second Generation Anti-CD20 Monoclonal Antibody
Third Generation Anti-CD20 Monoclonal Antibody
Segment by Application
Oncology
Neurology
Immunology
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Anti-CD20 Monoclonal Antibodies market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Anti-CD20 Monoclonal Antibodies market.
• The market share of the global Anti-CD20 Monoclonal Antibodies market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Anti-CD20 Monoclonal Antibodies market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Anti-CD20 Monoclonal Antibodies market.
1 Anti-CD20 Monoclonal Antibodies Market Overview
1.1 Anti-CD20 Monoclonal Antibodies Product Scope
1.2 Anti-CD20 Monoclonal Antibodies Segment by Type
1.2.1 Global Anti-CD20 Monoclonal Antibodies Sales by Type (2020-2026)
1.2.2 First Generation Anti-CD20 Monoclonal Antibody
1.2.3 Second Generation Anti-CD20 Monoclonal Antibody
1.2.4 Third Generation Anti-CD20 Monoclonal Antibody
1.3 Anti-CD20 Monoclonal Antibodies Segment by Application
1.3.1 Global Anti-CD20 Monoclonal Antibodies Sales Comparison by Application (2020-2026)
1.3.2 Oncology
1.3.3 Neurology
1.3.4 Immunology
1.4 Anti-CD20 Monoclonal Antibodies Market Estimates and Forecasts (2015-2026)
1.4.1 Global Anti-CD20 Monoclonal Antibodies Sales Growth Rate (2015-2026)
1.4.2 Global Anti-CD20 Monoclonal Antibodies Revenue and Growth Rate (2015-2026)
1.4.3 Global Anti-CD20 Monoclonal Antibodies Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Anti-CD20 Monoclonal Antibodies Industry Impact
1.5.1 How the Covid-19 is Affecting the Anti-CD20 Monoclonal Antibodies Industry
1.5.1.1 Anti-CD20 Monoclonal Antibodies Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Anti-CD20 Monoclonal Antibodies Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Anti-CD20 Monoclonal Antibodies Players to Combat Covid-19 Impact
2 Anti-CD20 Monoclonal Antibodies Estimate and Forecast by Region
2.1 Global Anti-CD20 Monoclonal Antibodies Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Anti-CD20 Monoclonal Antibodies Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Region (2015-2020)
2.2.2 Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Region (2015-2020)
2.3 Global Anti-CD20 Monoclonal Antibodies Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Anti-CD20 Monoclonal Antibodies Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Anti-CD20 Monoclonal Antibodies Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Anti-CD20 Monoclonal Antibodies Estimates and Projections (2015-2026)
2.4.2 Europe Anti-CD20 Monoclonal Antibodies Estimates and Projections (2015-2026)
2.4.3 China Anti-CD20 Monoclonal Antibodies Estimates and Projections (2015-2026)
2.4.4 Japan Anti-CD20 Monoclonal Antibodies Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Anti-CD20 Monoclonal Antibodies Estimates and Projections (2015-2026)
2.4.6 India Anti-CD20 Monoclonal Antibodies Estimates and Projections (2015-2026)
3 Global Anti-CD20 Monoclonal Antibodies Competition Landscape by Players
3.1 Global Top Anti-CD20 Monoclonal Antibodies Players by Sales (2015-2020)
3.2 Global Top Anti-CD20 Monoclonal Antibodies Players by Revenue (2015-2020)
3.3 Global Anti-CD20 Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-CD20 Monoclonal Antibodies as of 2019)
3.4 Global Anti-CD20 Monoclonal Antibodies Average Price by Company (2015-2020)
3.5 Manufacturers Anti-CD20 Monoclonal Antibodies Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Anti-CD20 Monoclonal Antibodies Players (Opinion Leaders)
4 Global Anti-CD20 Monoclonal Antibodies Market Size by Type
4.1 Global Anti-CD20 Monoclonal Antibodies Historic Market Review by Type (2015-2020)
4.1.1 Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2015-2020)
4.1.2 Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Type (2015-2020)
4.1.3 Global Anti-CD20 Monoclonal Antibodies Price by Type (2014-2020)
4.2 Global Anti-CD20 Monoclonal Antibodies Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Anti-CD20 Monoclonal Antibodies Sales Forecast by Type (2021-2026)
4.2.2 Global Anti-CD20 Monoclonal Antibodies Revenue Forecast by Type (2021-2026)
4.2.3 Global Anti-CD20 Monoclonal Antibodies Price Forecast by Type (2021-2026)
5 Global Anti-CD20 Monoclonal Antibodies Market Size by Application
5.1 Global Anti-CD20 Monoclonal Antibodies Historic Market Review by Application (2015-2020)
5.1.1 Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2015-2020)
5.1.2 Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Application (2015-2020)
5.1.3 Global Anti-CD20 Monoclonal Antibodies Price by Application (2015-2020)
5.2 Global Anti-CD20 Monoclonal Antibodies Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Anti-CD20 Monoclonal Antibodies Sales Forecast by Application (2021-2026)
5.2.2 Global Anti-CD20 Monoclonal Antibodies Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti-CD20 Monoclonal Antibodies Price Forecast by Application (2021-2026)
3 North America Anti-CD20 Monoclonal Antibodies Market Facts & Figures
3.2 North America Anti-CD20 Monoclonal Antibodies Sales Market Share by Company (2015-2020)
3.3 North America Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2015-2020)
3.4 North America Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2015-2020)
4 Europe Anti-CD20 Monoclonal Antibodies Market Facts & Figures
4.2 Europe Anti-CD20 Monoclonal Antibodies Sales Market Share by Company (2015-2020)
4.3 Europe Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2015-2020)
4.4 Europe Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2015-2020)
5 China Anti-CD20 Monoclonal Antibodies Market Facts & Figures
5.2 China Anti-CD20 Monoclonal Antibodies Sales Market Share by Company (2015-2020)
5.3 China Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2015-2020)
5.4 China Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2015-2020)
6 Japan Anti-CD20 Monoclonal Antibodies Market Facts & Figures
6.2 Japan Anti-CD20 Monoclonal Antibodies Sales Market Share by Company (2015-2020)
6.3 Japan Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2015-2020)
6.4 Japan Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2015-2020)
7 Southeast Asia Anti-CD20 Monoclonal Antibodies Market Facts & Figures
7.2 Southeast Asia Anti-CD20 Monoclonal Antibodies Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2015-2020)
8 India Anti-CD20 Monoclonal Antibodies Market Facts & Figures
8.2 India Anti-CD20 Monoclonal Antibodies Sales Market Share by Company (2015-2020)
8.3 India Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2015-2020)
8.4 India Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Anti-CD20 Monoclonal Antibodies Business
12.1 Genmab
12.1.1 Genmab Anti-CD20 Monoclonal Antibodies Corporation Information
12.1.2 Genmab Anti-CD20 Monoclonal Antibodies Business Overview and Total Revenue
12.1.3 Genmab Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Genmab Anti-CD20 Monoclonal Antibodies Products Offered
12.1.5 Genmab Recent Development
12.2 Amgen
12.2.1 Amgen Anti-CD20 Monoclonal Antibodies Corporation Information
12.2.2 Amgen Anti-CD20 Monoclonal Antibodies Business Overview and Total Revenue
12.2.3 Amgen Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Amgen Anti-CD20 Monoclonal Antibodies Products Offered
12.2.5 Amgen Recent Development
12.3 Celltrion
12.3.1 Celltrion Anti-CD20 Monoclonal Antibodies Corporation Information
12.3.2 Celltrion Anti-CD20 Monoclonal Antibodies Business Overview and Total Revenue
12.3.3 Celltrion Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Celltrion Anti-CD20 Monoclonal Antibodies Products Offered
12.3.5 Celltrion Recent Development
12.4 Roche
12.4.1 Roche Anti-CD20 Monoclonal Antibodies Corporation Information
12.4.2 Roche Anti-CD20 Monoclonal Antibodies Business Overview and Total Revenue
12.4.3 Roche Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Roche Anti-CD20 Monoclonal Antibodies Products Offered
12.4.5 Roche Recent Development
12.5 Novartis AG
12.5.1 Novartis AG Anti-CD20 Monoclonal Antibodies Corporation Information
12.5.2 Novartis AG Anti-CD20 Monoclonal Antibodies Business Overview and Total Revenue
12.5.3 Novartis AG Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Novartis AG Anti-CD20 Monoclonal Antibodies Products Offered
12.5.5 Novartis AG Recent Development
12.6 Pfizer
12.6.1 Pfizer Anti-CD20 Monoclonal Antibodies Corporation Information
12.6.2 Pfizer Anti-CD20 Monoclonal Antibodies Business Overview and Total Revenue
12.6.3 Pfizer Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Pfizer Anti-CD20 Monoclonal Antibodies Products Offered
12.6.5 Pfizer Recent Development
12.7 Biogen
12.7.1 Biogen Anti-CD20 Monoclonal Antibodies Corporation Information
12.7.2 Biogen Anti-CD20 Monoclonal Antibodies Business Overview and Total Revenue
12.7.3 Biogen Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Biogen Anti-CD20 Monoclonal Antibodies Products Offered
12.7.5 Biogen Recent Development
12.8 Genentech
12.8.1 Genentech Anti-CD20 Monoclonal Antibodies Corporation Information
12.8.2 Genentech Anti-CD20 Monoclonal Antibodies Business Overview and Total Revenue
12.8.3 Genentech Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Genentech Anti-CD20 Monoclonal Antibodies Products Offered
12.8.5 Genentech Recent Development
12.9 Immunomedics
12.9.1 Immunomedics Anti-CD20 Monoclonal Antibodies Corporation Information
12.9.2 Immunomedics Anti-CD20 Monoclonal Antibodies Business Overview and Total Revenue
12.9.3 Immunomedics Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Immunomedics Anti-CD20 Monoclonal Antibodies Products Offered
12.9.5 Immunomedics Recent Development
12.10 Spectrum Pharmaceuticals
12.10.1 Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies Corporation Information
12.10.2 Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies Business Overview and Total Revenue
12.10.3 Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies Products Offered
12.10.5 Spectrum Pharmaceuticals Recent Development
12.11 Bio-Rad Laboratories
12.11.1 Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Corporation Information
12.11.2 Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Business Overview and Total Revenue
12.11.3 Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Products Offered
12.11.5 Bio-Rad Laboratories Recent Development
12.12 LFB Biotechnologie
12.12.1 LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Corporation Information
12.12.2 LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Business Overview and Total Revenue
12.12.3 LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.12.4 LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Products Offered
12.12.5 LFB Biotechnologie Recent Development
13 Anti-CD20 Monoclonal Antibodies Manufacturing Cost Analysis
13.1 Anti-CD20 Monoclonal Antibodies Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Anti-CD20 Monoclonal Antibodies
13.4 Anti-CD20 Monoclonal Antibodies Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Anti-CD20 Monoclonal Antibodies Distributors List
14.3 Anti-CD20 Monoclonal Antibodies Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Anti-CD20 Monoclonal Antibodies Sales (KG) Growth Rate by Type (2020-2026)
Table 2. Global Anti-CD20 Monoclonal Antibodies Sales (KG) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Anti-CD20 Monoclonal Antibodies Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Anti-CD20 Monoclonal Antibodies Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Anti-CD20 Monoclonal Antibodies Players to Combat Covid-19 Impact
Table 8. Global Market Anti-CD20 Monoclonal Antibodies Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Anti-CD20 Monoclonal Antibodies Sales (KG) by Region (2015-2020)
Table 10. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Region (2015-2020)
Table 11. Global Anti-CD20 Monoclonal Antibodies Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Anti-CD20 Monoclonal Antibodies Revenue Share by Region (2015-2020)
Table 13. Global Anti-CD20 Monoclonal Antibodies Sales (KG) Forecast by Region (2021-2026)
Table 14. Global Anti-CD20 Monoclonal Antibodies Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Anti-CD20 Monoclonal Antibodies Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Anti-CD20 Monoclonal Antibodies Revenue Share Forecast by Region (2021-2026)
Table 17. Global Anti-CD20 Monoclonal Antibodies (KG) of Key Companies (2015-2020)
Table 18. Global Anti-CD20 Monoclonal Antibodies Sales Share by Company (2015-2020)
Table 19. Global Anti-CD20 Monoclonal Antibodies Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Anti-CD20 Monoclonal Antibodies Revenue Share by Company (2015-2020)
Table 21. Global Anti-CD20 Monoclonal Antibodies by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-CD20 Monoclonal Antibodies as of 2019)
Table 22. Global Anti-CD20 Monoclonal Antibodies Average Price (USD/KG) of Key Company (2015-2020)
Table 23. Manufacturers Anti-CD20 Monoclonal Antibodies Manufacturing Sites and Area Served
Table 24. Manufacturers Anti-CD20 Monoclonal Antibodies Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Anti-CD20 Monoclonal Antibodies Players
Table 27. Global Anti-CD20 Monoclonal Antibodies Sales (KG) by Type (2015-2020)
Table 28. Global Anti-CD20 Monoclonal Antibodies Sales Share by Type (2015-2020)
Table 29. Global Anti-CD20 Monoclonal Antibodies Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Anti-CD20 Monoclonal Antibodies Price (KG) by Type (2015-2020)
Table 31. Global Anti-CD20 Monoclonal Antibodies Sales Share by Type (2021-2026)
Table 32. Global Anti-CD20 Monoclonal Antibodies Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Anti-CD20 Monoclonal Antibodies Revenue Share by Type (2021-2026)
Table 34. Global Anti-CD20 Monoclonal Antibodies Price (KG) by Type (2021-2026)
Table 35. Global Anti-CD20 Monoclonal Antibodies Sales (KG) by Application (2015-2020)
Table 36. Global Anti-CD20 Monoclonal Antibodies Sales Share by Application (2015-2020)
Table 37. Global Anti-CD20 Monoclonal Antibodies Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Anti-CD20 Monoclonal Antibodies Price (KG) by Application (2015-2020)
Table 39. Global Anti-CD20 Monoclonal Antibodies Sales (KG) by Application (2021-2026)
Table 40. Global Anti-CD20 Monoclonal Antibodies Sales Share by Application (2021-2026)
Table 41. Global Anti-CD20 Monoclonal Antibodies Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Anti-CD20 Monoclonal Antibodies Revenue Share by Application (2021-2026)
Table 43. Global Anti-CD20 Monoclonal Antibodies Price (KG) by Application (2021-2026)
Table 44. United States Anti-CD20 Monoclonal Antibodies Sales (KG) by Company (2015-2020)
Table 45. United States Anti-CD20 Monoclonal Antibodies Sales Market Share by Company (2015-2020)
Table 46. United States Anti-CD20 Monoclonal Antibodies Sales (KG) by Type (2015-2020)
Table 47. United States Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2015-2020)
Table 48. United States Anti-CD20 Monoclonal Antibodies Sales (KG) by Application (2015-2020)
Table 49. United States Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2015-2020)
Table 50. Europe Anti-CD20 Monoclonal Antibodies Sales (KG) by Company (2015-2020)
Table 51. Europe Anti-CD20 Monoclonal Antibodies Sales Market Share by Company (2015-2020)
Table 52. Europe Anti-CD20 Monoclonal Antibodies Sales (KG) by Type (2015-2020)
Table 53. Europe Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2015-2020)
Table 54. Europe Anti-CD20 Monoclonal Antibodies Sales (KG) by Application (2015-2020)
Table 55. Europe Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2015-2020)
Table 56. China Anti-CD20 Monoclonal Antibodies Sales (KG) by Company (2015-2020)
Table 57. China Anti-CD20 Monoclonal Antibodies Sales Market Share by Company (2015-2020)
Table 58. China Anti-CD20 Monoclonal Antibodies Sales (KG) by Type (2015-2020)
Table 59. China Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2015-2020)
Table 60. China Anti-CD20 Monoclonal Antibodies Sales (KG) by Application (2015-2020)
Table 61. China Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2015-2020)
Table 62. Japan Anti-CD20 Monoclonal Antibodies Sales (KG) by Company (2015-2020)
Table 63. Japan Anti-CD20 Monoclonal Antibodies Sales Market Share by Company (2015-2020)
Table 64. Japan Anti-CD20 Monoclonal Antibodies Sales (KG) by Type (2015-2020)
Table 65. Japan Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2015-2020)
Table 66. Japan Anti-CD20 Monoclonal Antibodies Sales (KG) by Application (2015-2020)
Table 67. Japan Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Anti-CD20 Monoclonal Antibodies Sales (KG) by Company (2015-2020)
Table 69. Southeast Asia Anti-CD20 Monoclonal Antibodies Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Anti-CD20 Monoclonal Antibodies Sales (KG) by Type (2015-2020)
Table 71. Southeast Asia Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Anti-CD20 Monoclonal Antibodies Sales (KG) by Type (2015-2020)
Table 73. Southeast Asia Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2015-2020)
Table 74. India Anti-CD20 Monoclonal Antibodies Sales (KG) by Company (2015-2020)
Table 75. India Anti-CD20 Monoclonal Antibodies Sales Market Share by Company (2015-2020)
Table 76. India Anti-CD20 Monoclonal Antibodies Sales (KG) by Type (2015-2020)
Table 77. India Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2015-2020)
Table 78. India Anti-CD20 Monoclonal Antibodies Sales (KG) by Application (2015-2020)
Table 79. India Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2015-2020)
Table 80. Genmab Corporation Information
Table 81. Genmab Description and Business Overview
Table 82. Genmab Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 83. Genmab Anti-CD20 Monoclonal Antibodies Product
Table 84. Genmab Recent Development
Table 85. Amgen Corporation Information
Table 86. Amgen Description and Business Overview
Table 87. Amgen Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 88. Amgen Anti-CD20 Monoclonal Antibodies Product
Table 89. Amgen Recent Development
Table 90. Celltrion Corporation Information
Table 91. Celltrion Description and Business Overview
Table 92. Celltrion Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 93. Celltrion Anti-CD20 Monoclonal Antibodies Product
Table 94. Celltrion Recent Development
Table 95. Roche Corporation Information
Table 96. Roche Description and Business Overview
Table 97. Roche Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 98. Roche Anti-CD20 Monoclonal Antibodies Product
Table 99. Roche Recent Development
Table 100. Novartis AG Corporation Information
Table 101. Novartis AG Description and Business Overview
Table 102. Novartis AG Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 103. Novartis AG Anti-CD20 Monoclonal Antibodies Product
Table 104. Novartis AG Recent Development
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 108. Pfizer Anti-CD20 Monoclonal Antibodies Product
Table 109. Pfizer Recent Development
Table 110. Biogen Corporation Information
Table 111. Biogen Description and Business Overview
Table 112. Biogen Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 113. Biogen Anti-CD20 Monoclonal Antibodies Product
Table 114. Biogen Recent Development
Table 115. Genentech Corporation Information
Table 116. Genentech Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 117. Genentech Description and Business Overview
Table 118. Genentech Anti-CD20 Monoclonal Antibodies Product
Table 119. Genentech Recent Development
Table 120. Immunomedics Corporation Information
Table 121. Immunomedics Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 122. Immunomedics Description and Business Overview
Table 123. Immunomedics Anti-CD20 Monoclonal Antibodies Product
Table 124. Immunomedics Recent Development
Table 125. Spectrum Pharmaceuticals Corporation Information
Table 126. Spectrum Pharmaceuticals Description and Business Overview
Table 127. Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 128. Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies Product
Table 129. Spectrum Pharmaceuticals Recent Development
Table 130. Bio-Rad Laboratories Corporation Information
Table 131. Bio-Rad Laboratories Description and Business Overview
Table 132. Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table 133. Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Product
Table 134. Bio-Rad Laboratories Recent Development
Table . LFB Biotechnologie Corporation Information
Table . LFB Biotechnologie Description and Business Overview
Table . LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2015-2020)
Table . LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Product
Table . LFB Biotechnologie Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Anti-CD20 Monoclonal Antibodies Distributors List
Table 143. Anti-CD20 Monoclonal Antibodies Customers List
Table 144. Market Key Trends
Table 145. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 146. Key Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-CD20 Monoclonal Antibodies Product Picture
Figure 2. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Anti-CD20 Monoclonal Antibodies Market Share by Application in 2020 & 2026
Figure 6. Oncology Examples
Figure 7. Neurology Examples
Figure 8. Immunology Examples
Figure 9. Global Anti-CD20 Monoclonal Antibodies Sales (KG) Growth Rate (2015-2026)
Figure 10. Global Anti-CD20 Monoclonal Antibodies Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Anti-CD20 Monoclonal Antibodies Price Trends Growth Rate (2015-2026) (USD/KG)
Figure 12. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Anti-CD20 Monoclonal Antibodies Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Anti-CD20 Monoclonal Antibodies Sales (KG) Growth Rate (2015-2026)
Figure 16. Europe Anti-CD20 Monoclonal Antibodies Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Anti-CD20 Monoclonal Antibodies Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Anti-CD20 Monoclonal Antibodies Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Anti-CD20 Monoclonal Antibodies Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Anti-CD20 Monoclonal Antibodies Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Anti-CD20 Monoclonal Antibodies Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Anti-CD20 Monoclonal Antibodies Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Anti-CD20 Monoclonal Antibodies Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Anti-CD20 Monoclonal Antibodies Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Anti-CD20 Monoclonal Antibodies Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Anti-CD20 Monoclonal Antibodies Players Market Share by Revenue in Anti-CD20 Monoclonal Antibodies 2015 & 2019
Figure 27. Anti-CD20 Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Anti-CD20 Monoclonal Antibodies Revenue Share by Type (2015-2020)
Figure 29. Global Anti-CD20 Monoclonal Antibodies Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Anti-CD20 Monoclonal Antibodies Revenue Share by Application (2015-2020)
Figure 31. Global Anti-CD20 Monoclonal Antibodies Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Anti-CD20 Monoclonal Antibodies Sales Market Share by Type in 2019
Figure 33. United States Anti-CD20 Monoclonal Antibodies Sales Market Share by Type in 2019
Figure 34. Europe Anti-CD20 Monoclonal Antibodies Sales Market Share by Company in 2019
Figure 35. Europe Anti-CD20 Monoclonal Antibodies Sales Market Share by Type in 2019
Figure 36. Europe Anti-CD20 Monoclonal Antibodies Sales Market Share by Application in 2019
Figure 37. China Anti-CD20 Monoclonal Antibodies Sales Market Share by Company in 2019
Figure 38. China Anti-CD20 Monoclonal Antibodies Sales Market Share by Type in 2019
Figure 39. China Anti-CD20 Monoclonal Antibodies Sales Market Share by Application in 2019
Figure 40. Japan Anti-CD20 Monoclonal Antibodies Sales Market Share by Company in 2019
Figure 41. Japan Anti-CD20 Monoclonal Antibodies Sales Market Share by Type in 2019
Figure 42. Japan Anti-CD20 Monoclonal Antibodies Sales Market Share by Application in 2019
Figure 43. Southeast Asia Anti-CD20 Monoclonal Antibodies Sales Market Share by Company in 2019
Figure 44. Southeast Asia Anti-CD20 Monoclonal Antibodies Sales Market Share by Type in 2019
Figure 45. Southeast Asia Anti-CD20 Monoclonal Antibodies Sales Market Share by Application in 2019
Figure 46. India Anti-CD20 Monoclonal Antibodies Sales Market Share by Company in 2019
Figure 47. India Anti-CD20 Monoclonal Antibodies Sales Market Share by Type in 2019
Figure 48. India Anti-CD20 Monoclonal Antibodies Sales Market Share by Application in 2019
Figure 49. Genmab Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Celltrion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Biogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Genentech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Immunomedics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Spectrum Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. LFB Biotechnologie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Key Raw Materials Price Trend
Figure 62. Manufacturing Cost Structure of Anti-CD20 Monoclonal Antibodies
Figure 63. Manufacturing Process Analysis of Anti-CD20 Monoclonal Antibodies
Figure 64. Anti-CD20 Monoclonal Antibodies Industrial Chain Analysis
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Figure 67. Porter's Five Forces Analysis
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
モノクローナル抗体の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Monoclonal Antibodies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Monoclonal Antibodies m…- モノクローナル抗体診断試薬の世界市場レポート2020 A recently published report by QY Research titled Global Monoclonal Antibody Diagnostic Reagents Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistica…
- 研究用抗体の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Research Antibodies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.4% in the forecast period of 2020 to 2025 and will expected to reach USD 9979.6 million by 2025, from USD 8742.5 million in 2019. The Research Antibod…
- 反射防止ガラスの世界市場レポート2020 Market Analysis and Insights: Global Anti-Reflection Glass Market The global Anti-Reflection Glass market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Anti-Reflection Glass Scope and Market Size The global An…
- 抗幼若ホルモンの世界市場レポート2020 Market Analysis and Insights: Global Anti Juvenile Hormone Market The global Anti Juvenile Hormone market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Anti Juvenile Hormone Scope and Market Size The global An…